Control of hypoxia-induced tumor cell adhesion by cytophilic human catalase

Free Radical Biology and Medicine

Volumn 47, Issue 12, 2009, Pages 1772-1778

  Yata, Tomoya ^a   Nishikawa, Makiya ^a   Nishizaki, Chika ^a   Oku, Masahide ^a   Yurimoto, Hiroya ^a   Sakai, Yasuyoshi ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Abnormal cell adhesion; Free radicals; Hypoxia; Reactive oxygen species; Recombinant human catalase

Indexed keywords

ARGININE; ASPARTIC ACID; CATALASE; GLYCINE; HYPOXIA INDUCIBLE FACTOR 1; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BINDING; ENZYME STRUCTURE; HUMAN; HYPOXIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; PRIORITY JOURNAL; TUMOR CELL; VASCULAR ENDOTHELIUM;

ANIMALS; CATALASE; CATS; CELL ADHESION; CELL HYPOXIA; ENDOTHELIUM, VASCULAR; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1; MICE; NEOPLASMS; NF-KAPPA B; OLIGOPEPTIDES; REACTIVE OXYGEN SPECIES; RECOMBINANT FUSION PROTEINS;

PICHIA PASTORIS;

EID: 70449528510     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.09.027     Document Type: Article

References (34)

1. Michiels C., Arnould T., and Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim. Biophys. Acta 1 (2000) 1-10
2. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., and Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 4 (1996) 672-682
3. Tailor A., and Granger D.N. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler. Thromb. Vasc. Biol. 4 (2003) 675-680
4. Dittmar T., Heyder C., Gloria-Maercker E., Hatzmann W., and Zänker K.S. Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin. Exp. Metastasis 1 (2008) 11-32
5. Vaupel P., Kallinowski F., and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 23 (1989) 6449-6465
6. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., and Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 20 (1998) 11715-11720
7. 2 sensing. J. Biol. Chem. 33 (2000) 25130-25138
8. Ma S.F., Nishikawa M., Katsumi H., Yamashita F., and Hashida M. Liver targeting of catalase by cationization for prevention of acute liver failure in mice. J. Control. Release 2 (2006) 273-282
9. Opanasopit P., Nishikawa M., and Hashida M. Factors affecting drug and gene delivery: effects of interaction with blood components. Crit. Rev. Ther. Drug Carrier Syst. 3 (2002) 191-233
10. Nishiyama T., Mishima K., Ide F., Yamada K., Obara K., Sato A., Hitosugi N., Inoue H., Tsubota K., and Saito I. Functional analysis of an established mouse vascular endothelial cell line. J. Vasc. Res. 2 (2007) 138-148
11. Hyoudou K., Nishikawa M., Umeyama Y., Kobayashi Y., Yamashita F., and Hashida M. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin. Cancer Res. 22 (2004) 7685-7691
12. Hyoudou K., Nishikawa M., Kobayashi Y., Mukai S., Ikemura M., Kuramoto Y., Yamashita F., and Hashida M. Inhibition of peritoneal dissemination of tumor cells by cationized catalase in mice. J. Control. Release 1 (2007) 121-127
13. Ogawara K., Un K., Minato K., Tanaka K., Higaki K., and Kimura T. Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors. Int. J. Pharm. 1-2 (2008) 234-240
14. Nomura T., Yasuda K., Yamada T., Okamoto S., Mahato R.I., Watanabe Y., Takakura Y., and Hashida M. Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther. 1 (1999) 121-129
15. Sears I.B., O'Connor J., Rossanese O.W., and Glick B.S. A versatile set of vectors for constitutive and regulated gene expression in Pichia pastoris. Yeast 14 (1998) 783-790
16. Purdue P.E., and Lazarow P.B. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J. Cell Biol. 4 (1996) 849-862
17. Purdue P.E., Castro S.M., Protopopov V., and Lazarow P.B. Targeting of human catalase to peroxisomes is dependent upon a novel C-terminal peroxisomal targeting sequence. Ann. N. Y. Acad. Sci. 804 (1996) 775-776
18. Takahashi Y., Nishikawa M., and Takakura Y. Inhibition of tumor cell growth in the liver by RNA interference-mediated suppression of HIF-1alpha expression in tumor cells and hepatocytes. Gene Ther. 8 (2008) 572-582
19. Baker R.D., Cook C.O., and Goodwin D.C. Properties of catalase-peroxidase lacking its C-terminal domain. Biochem. Biophys. Res. Commun. 3 (2004) 833-839
20. Turpaev K.T. Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc.) 3 (2002) 281-292
21. Yabe Y., Kobayashi N., Nishihashi T., Takahashi R., Nishikawa M., Takakura Y., and Hashida M. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J. Pharmacol. Exp. Ther. 3 (2001) 894-899
22. Ma S.F., Nishikawa M., Hyoudou K., Takahashi R., Ikemura M., Kobayashi Y., Yamashita F., and Hashida M. Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity. Kidney Int. 12 (2007) 1474-1482
23. Hyoudou K., Nishikawa M., Kobayashi Y., Umeyama Y., Yamashita F., and Hashida M. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic. Biol. Med. 9 (2006) 1449-1458
24. Hyoudou K., Nishikawa M., Kobayashi Y., Mukai S., Ikemura M., Kuramoto Y., Yamashita F., and Hashida M. Inhibition of peritoneal dissemination of tumor cells by cationized catalase in mice. J. Control. Release 1 (2007) 121-127
25. Dayan A.D. Safety evaluation of biological and biotechnology-derived medicines. Toxicology 1 (1995) 59-68
26. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 5433 (1999) 1569-1572
27. Dickerson E.B., Akhtar N., Steinberg H., Wang Z.Y., Lindstrom M.J., Padilla M.L., Auerbach R., and Helfand S.C. Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to alphavbeta3 integrin. Mol. Cancer Res. 12 (2004) 663-673
28. Han K., Jeon M.J., Kim S.H., Ki D., Bahn J.H., Lee K.S., Park J., and Choi S.Y. Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides. Mol. Cells 2 (2001) 267-271
29. Temming K., Schiffelers R.M., Molema G., and Kok R.J. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist. Updat. 6 (2005) 381-402
30. Nakase I., Takeuchi T., Tanaka G., and Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev. 4-5 (2008) 598-607
31. Kurihara H., and Nagamune T. Cell adhesion ability of artificial extracellular matrix proteins containing a long repetitive Arg-Gly-Asp sequence. J. Biosci. Bioeng. 1 (2005) 82-87
32. Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett. 266 (2008) 53-59
33. Putnam C.D., Arvai A.S., Bourne Y., and Tainer J.A. Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism. J. Mol. Biol. 1 (2000) 295-309
34. Engers R., and Gabbert H.E. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J. Cancer Res. Clin. Oncol. 126 (2000) 682-692